Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...
Researchers use cryo-EM and optical tweezers to investigate how an antiviral interacts with the herpes simplex virus.
Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.
March 21, 2012 (San Diego, California) — A novel helicase-primase inhibitor with antiviral activity against the varicella zoster virus might provide an alternative as potent as current treatments for ...
CDT1 inhibits the helicase activity of the MCM complex, thereby suppressing nascent strand synthesis in DNA replication in cultured human cells. This action results in fork collapse and DNA damage, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results